Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Curcumin in Women With PCOS and NAFLD
NCT07278128Phase 3Completed
- Start
- Jun 2024
- Primary completion
- Jul 2025
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of curcumin in polycystic ovary syndrome (PCOS), non-alcoholic fatty liver disease (NAFLD). Started Jun 2024; status: completed.
02
Drugs
curcumin
03
Conditions
polycystic ovary syndrome (PCOS)non-alcoholic fatty liver disease (NAFLD)
Beyond the preview
Go deeper on NCT07278128.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07278128.